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Micromanagement in the gut: microenvironmental factors
govern colon mucosal bioﬁlm structure and functionality
Rosemarie De Weirdt1 and Tom Van de Wiele1
The human gut microbiome provides us with functional features that we did not have to evolve ourselves and can be viewed as a
structured microbial community that operates like a microbial organ within the human host. A minor but important part of this
microbiome is the ability to colonise and thrive within the mucous layer that covers the colon epithelium. These mucosal microbes
intimately interact with the intestinal tissue and seem to be important modulators of human health. Embedded in the host-secreted
mucous matrix, they form a ‘mucosal bioﬁlm’ with a distinct composition and functionality. In this review, we provide evidence that
six speciﬁc (micro)environmental factors near the colon mucosa shape and determine mucosal bioﬁlm formation and stability, that
is, (1) mucous rigidity, (2) gradients of ﬂuid shear, (3) radial oxygen gradients, (4) secretions of host defense molecules, (5) the
presence of a rich but challenging nutrient platform and (6) the presence of niches at the colon epithelial surface. In addition,
it appears that microbes actively participate in shaping their mucosal environment. Current insights into the interaction between
mucosal microbes and their environment are rather limited, and many questions regarding the contribution of mucosal bioﬁlm
functionality and stability to human health remain to be answered. Yet, given the higher potency of mucosal microbes than their
luminal counterparts to interact with the host, new insights can accelerate the development of novel disease-preventive or
therapeutic strategies.
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The human colon harbours a highly dense microbial community
of 1011–1012 cells per gram of gut content.1,2 Although the
majority of this community thrives in the lumen, few microbes can
be found within the protective mucous layer that covers the
epithelial cells (105–106 cells per ml of mucus).3 These microbes
form the colon ‘mucosal bioﬁlm’. Mucosal bioﬁlms were previously
deﬁned as microbial bioﬁlms that are unique to the mucosal
environment.4 In contrast to bioﬁlms that grow on inert surfaces,
they are modulated by host inﬂammatory responses, and host
proteins and cells contribute to the composition of the
extracellular matrix.4 Healthy colon mucosal bioﬁlms typically
have low microbial densities,5 and growth of complex mushroom-
shaped structures that are common for mature bioﬁlms (indicated
as stage 4 by Stoodley et al.6) have thus far not been observed.
Hence, from a microbial point of view, we infer that the colon
mucosal bioﬁlm should be regarded as an immature bioﬁlm.
The mucosal bioﬁlm is unique in composition compared with
the microbial populations that colonise the large intestinal lumen
and make up faeces.7–9 At the phylum level, colon mucosal
biopsies are enriched in Firmicutes (especially members of the
Lachnospiraeceae and Ruminococcaceae families) compared with
luminal or faecal samples.10–12 At the genus level, abundant and
ubiquitous mucosal members are Bacteroides, Faecalibacterium,
Roseburia, Blautia and a series of lactic acid bacteria classiﬁed as
Leuconostoc, Weissella, Lactococcus and Streptococcus.13,14
Mucosal microbes intimately interact with the gut epithelium
and gut-associated lymphoid tissue,15–17 and are increasingly
evidenced to be important modulators of human health. On one
hand, their abundance and prevalence is associated with disease.
Low levels of Faecalibacterium prausnitzii have been correlated
with active IBD and infectious colitis,18 quiescent ileal Crohn’s
disease19 and colorectal adenomas.20 On the other hand, mucosal
species (Bacteroides fragilis, Lactobacillus reuteri) have been shown
to protect against experimentally induced colitis in animal
models.21,22 Interestingly, members of the mucosal microbiome
are found to possess distinct functionalities that are not expressed
in standard in vitro set-ups. One such example is the extremely
oxygen-sensitive F. prausnitzii species, which has been described
to use an exogenous ﬂavin-thiol electron shuttle to cope with
elevated oxidative stress in the mucosal environment.23 The case
of F. prausnitzii is one of many examples showing how
physicochemical conditions in the gut mucosa determine
microbial colonisation processes.
We review the current knowledge on how the speciﬁc
physicochemical conditions near the colon mucosa shape the
mucosal bioﬁlm composition and functionality of a healthy, adult
colon and vice versa. Data of the small intestinal mucosa are not
considered, because of its different physiology and interaction
with gut microbes.24 On the basis of this analysis, we argue that a
better understanding of the speciﬁc interactions between mucosal
microbes and their environment is essential for exploring the full
potential of gut microbes to modulate human health.
The major environmental factor shaping the mucosal bioﬁlm
is mucus. Colon mucus—in contrast to the unattached and
discontinuous mucous layer in the small intestine—is present as a
thick and continuous layer.25,26 It forms a viscoelastic, permeable
gel that lubricates and protects the colon epithelial cells against
foreign particles and microbial invasion while selectively allowing
for the transport of gases, ions, nutrients and proteins.27 These
selective barrier properties are determined by its biochemical
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composition, with the most important constituents being
gel-forming mucins. Mucins are densely glycosylated
glycoproteins that are cross-linked and assembled via disulphide
bonds, and often negatively charged with sialic acids or sulphate
groups. In the colon, Muc2 mucins are the only gel-forming
mucins.28 Colon Muc2 mucins form two distinct layers: a ﬁrm, cell-
adherent inner mucous layer, and a loose, unattached outer
mucous layer.26,29 The inner mucous layer is a thin, lamellar, highly
organised layer of densely stacked Muc2 mucins that remain
anchored to the epithelial cells. It has a thickness of several
hundred micrometres.30 The outer mucous layer is formed from
the inner layer by proteolytic cleavages allowing the Muc2 mucin
to expand three to four times into a loose polymeric network
removable by suction.31 The rigidity and viscosity of mucus may
further ﬂuctuate, as mucin glycosylation patterns, their charge and
their degree of cross-linking are highly responsive to the exact
concentration of other mucous constituents such as water, lipids,
ions, DNA, proteins, cells and cellular debris.27 For example, high
concentrations of calcium can entirely collapse the mucus gel by
facilitating protein cross-links between mucin monomers,32 while
high acidity can decrease the viscosity of mucus by reducing the
negative charges on sialic acids.33
Another intrinsic feature of the colon mucous layer is its rapid
turnover time. A recent mouse study has revealed that the inner
mucous layer is fully renewed within 1 h,34 while the gut
epithelium tissue is self-renewed within 4–5 days.35 Hence, it is
clear that mucus forms a remarkable and sensitive niche for
microbial life, in which microbes are challenged to adapt to the
biochemical dynamics determining mucous viscoelasticity and to
persist within a continuously renewed environment.
We identify six microenvironmental conditions in the mucosal
bioﬁlm that have been evidenced to impact microbial colonisation
and functionality (Figure 1). First, the increased rigidity of the inner
mucous layer is shown to physically interfere with the migration of
microbes. Mucosal microbes mostly colonise the looser, outer
mucous layer, whereas the inner, ﬁrmer layer is reported to be
largely devoid of or contain very low numbers of bacteria.22,31
In rats, the inner mucous layer was furthermore shown to have a
distinct bacterial community composition.22 Indeed, differences in
viscosity were found to signiﬁcantly select for microbes with a
different morphology.36 Low viscosity selects for short coccoid
rods like Bacteroides spp., a moderately viscous environment is
preferred by long curved rods like Eubacterium rectale, and a high
viscosity immobilizes all bacterial groups.36 Gradients in mucous
rigidity may further select for microbes that developed tools to
attach to and/or migrate within the mucous layer. These tools are
typically extracellular protein polymers like ﬂagella, pili and
ﬁmbriae.37 Pili and ﬁmbriae are mostly used for adherence to
epithelial cells and mucus, while ﬂagella additionally enable
microbes to swim and swarm across the mucus. These structures
have extensively been studied in human intestinal pathogens and
are important for colonisation of the host tissue and virulence.38
However, they may also be important for mucous colonisation by
beneﬁcial microbes, as adherent pili and ﬁmbriae have been
identiﬁed in L. rhamnosus GG39 and Biﬁdobacterium breve.40
Moreover, a variety of Lactobacillus spp. was found to possess
mucus-binding proteins that enable adhesion to a wide range of
mucous ligands.37 Finally, it was suggested that commensal
mucus-binding Bacteroides spp. utilise extracellular proteins
that bind starch and other carbohydrates on the mucin
glycoproteins.41
Interestingly, there is increasing evidence that gut microbes
may actively participate in regulating mucous viscosity. A recent
study with two colonies of genetically identical mice showed that
the presence of a speciﬁc gut microbiome may determine the
strength of the mucous barrier.42 The ﬁrst mouse colony had an
inner mucous layer that was impenetrable by bacteria or beads of
the same size, whereas the inner mucous layer of the second
colony was penetrable by bacteria and beads. The mucous
phenotypes depended on the gut microbiome because they were
transmissible by transfer of caecal microbiota to germ-free mice.
At the biochemical level, evidence for a microbial impact on
mucous viscosity and penetrability is provided by study of the
human commensal F. prausnitzii. F. prausnitzii growth in the
oxygenated mucosal bioﬁlm was found to require free pools of
thiols, such as cysteine and glutathione.23 These are redox
mediators and are important for maintaining mucous ﬂuidity
while they can modulate reduction of the disulphide bonds that
assemble the mucin glycoproteins into polymeric networks.43
Hence, F. prausnitzii growth and mucous rigidity rely on the same
biochemical products, and might be closely connected.
Second, differences in rigidity between inner and outer mucous
layer expose the mucosal microbes to gradients of ﬂuid shear.
Microbes that reside between the microvilli of the epithelial cells
are exposed to a low ﬂuid shear environment44 and experience
much less physical perturbation when compared with the
microbes in the outer, more turbulent mucous layer. Low ﬂuid
shear was shown to completely reprogramme the gene
expression, physiology and stress resistance of several
(opportunistic) pathogens, including Salmonella enterica serovar
Typhimurium (for which virulence was also altered), Escherichia
coli, Pseudomonas aeruginosa and Staphylococcus aureus.44–46
The latter two organisms also showed alterations in bioﬁlm
formation.46,47 In the case of S. aureus, low ﬂuid shear conditions
that altered bioﬁlm architecture made the bacterium more
resistant to antibiotic stress, lowered its resistance to oxidative
stress and decreased carotenoid production.46 Although the
impact of low ﬂuid shear on commensal gut microbes has not
been described so far, it seems plausible that mucous ﬂuidity and
shear are important determinants of mucosal bioﬁlm structure
and functionality.
Third, microbial life in the mucosal bioﬁlm experiences
gradients in oxygen, which leaks from the epithelial cells and
dilutes into the mucous layer. Albenberg et al. recently measured
a steep and radial oxygen gradient in the mice caecum going from
40mm Hg in the intestinal tissue to deeply anaerobic conditions
(o1mmHg) in the bulk of the lumen.48 For the ﬁrst time, these
authors demonstrated the potential of oxygen to shape the
(mucosal) gut microbiome. They increased the oxygenation of
mouse intestinal tissues by hyperbaric oxygen therapy, and found
shifts in their faecal microbial composition. Moreover, in humans,
the authors found that rectal mucosal biopsies and swabs
contained a higher relative abundance of oxygen-tolerant
Proteobacteria and Actinobacteria when compared with paired
stool samples.
Additional evidence for oxygen gradients to shape mucosal
bioﬁlm formation is provided by the fact that prominent strictly
anaerobic mucosal microbes seem to beneﬁt from low oxygen
concentrations. As mentioned previously in this text, F. prausnitzii
species were found to tolerate low concentrations of oxygen by
using an extracellular electron shuttle of ﬂavins and thiols.23 This
way of electron shuttling to oxygen results in a competitive
growth advantage and may explain why F. prausnitzii is found
in vivo and in vitro in the outer mucous layer and lumen/mucus
interphase.19,49,50 Another mechanism by which gut microbes may
beneﬁt from low oxygen levels near the gut mucosa was found in
Bacteroides fragilis. This species encodes cytochrome bd oxidase,
an essential enzyme for oxygen consumption that was shown to
stimulate its growth in the presence of nanomolar concentrations
of oxygen.51 This feature explains why strictly anaerobic
Bacteroides spp. are able to colonise the mouse intestine without
pre-colonisation by facultative anaerobes that reduce oxygen
creating a strictly anaerobic environment.52 Cytochrome oxidases
seem to be widespread in the genome of (gut) bacterial species
belonging to different phyla, among which are found many
human intestinal pathogens.51,53 Hence, it is likely that a variety of
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Figure 1. Schematic overview of six microenvironmental factors near the colon epithelium that are evidenced to impact mucosal microbial
colonisation and functionality.
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microbes and pathogens are beneﬁting from low oxygen levels
near the colon epithelial surface.53
Finally, increased oxygen availability upon migration to the
colonic mucosal surface was found to enhance the adhesive and/
or invasive properties of human enteric pathogens that infect
colon epithelial cells, including Salmonella enterica,54,55 Shigella
ﬂexneri56 and enterohaemorrhagic Escherichia coli.57 Radial oxygen
gradients in the colon mucous layer may thus also have a role in
disease and the disruption of the normal microbiota.
A fourth factor shaping colon mucosal colonisation patterns is
the secretion of host defense molecules such as antimicrobial
peptides (AMPs) and secretory IgA, by the colon epithelial cells. In
comparison with the small intestinal epithelium, colon epithelial
cells are secreting much lower amounts of AMPs and sIgA than
small intestinal epithelium.25 This is due to their different
physiology: AMP-secreting Paneth cells are abundant in the small
intestine but rare in the colon, and sIgA-regulation by aggregated
lymphoid nodules (Peyer’s patches) in the small intestine is taken
over by smaller, isolated lymphoid follicles in the colon.25 Yet, the
antimicrobial activity in the colon mucosal bioﬁlm should not be
underestimated. It has been shown that secretions of AMPs
remain trapped in the mucus and only marginally leach to the
lumen.58 In addition, AMPs can also be produced by mouse Goblet
cells, which are mucus-secreting enterocytes that are highly
abundant in the colon.59 Although the presence of these
antimicrobial components in the mucous layer impacts the
colonisation ability of several microorganisms, mucosal microbes
themselves are capable to regulate their secretion and thereby
modify the mucosal microbiome. Bacteroides thetaiotaomicron has
been described to shape innate immunity by modulating
antimicrobial angiogenin4 production by mouse Paneth cells.60
Another example is the inducation of RegIIIγ production in the
mouse colon, not ileum, by the mucinolytic Akkermansia
muciniphila. As RegIIIγ exerts direct antimicrobial activity against
gram-positive microbes in the intestine,61 A. muciniphila is thus
able to favour its own colonisation and growth. Hence, we infer
that colon mucosal bioﬁlm formation is shaped by the build-up of
host defense molecules in the thick mucous layer, with
antimicrobial activities comparable to (or even greater than)
those in the small intestine.
A ﬁfth factor that determines whether microbes are able to
persist within the mucous layer is the presence of a rich but
challenging nutrient platform. Mucosal microbes may feed or
cross-feed on ‘easy’ substrates that are leaching from the lumen in
the (outer) mucous layer or that are produced in the bioﬁlm.
However, it appears that the colon mucosal nutrient platform is
dominated by less degradable host-derived secretions. Indeed,
the composition of the mucosal bioﬁlm was evidenced to be
enriched in asaccharolytic microbes that primarily metabolise
peptones and amino acids, which are probably derived from the
proteinaceous substrates from mucus and shedded epithelium.48
In the mouse caecum, stable isotope probing with threonine
revealed that two bacterial species, A. muciniphila and Bacteroides
acidifaciens, are key host-protein foragers in vivo.62 A. muciniphila
and Bacteroides spp. are dominant members of the human colon
microbiome8,63 that have been shown to degrade mucin
glycoproteins.64,65 Bacteroides spp. and A. muciniphila have
evolved rather different strategies to forage on mucin. Although
Bacteroides spp. have broad polysaccharide degradation
potential66 and only turn to mucin glycans when dietary glycans
are depleted,67 A. muciniphila has specialized to utilise mucins as a
sole carbon and nitrogen source.63,64 For B. thetaiotaomicron,
foraging on mucin glycans was found to be important for
successful colonisation of the mouse gut, because deletion of
the involved gene cassettes was shown to compromise its
transmission from gnotobiotic mother to offspring.68 Hence, its
capacity to thrive on mucin glycans and live in close proximity to
the intestinal epithelial surface seems to be an evolutionary trait
allowing for its stable and continuous colonisation of the gut. For
A. muciniphila, foraging on mucin seems not to conﬁne the species
to the mucosal bioﬁlm niche. In our dynamic in vitro model of the
proximal and distal colon microbiome (SHIME),69,70 A. muciniphila
was found to abundantly colonise the distal colon compartment in
the absence of a mucosal bioﬁlm. Moreover, supplementation of
mucin to this model resulted in a strong and quick increase in
luminal A. muciniphila qPCR counts (4.5 log increase in 2 days)
(unpublished data). In addition, A. muciniphila seems not to bind
to human colon mucus.71 Considering A. muciniphila’s unique
specialisation to grow on mucin, we infer that its in vivo niche is
associated with mucus regardless of their embedment within the
colon mucosal bioﬁlm or not.
Although some mucosal species directly beneﬁt from host-
secreted mucin, their activity was found to depend on the
presence of other community members.62,72 Indeed, complete
degradation of the heterogeneous and complex structure of
mucin glycoproteins requires a diverse set of enzymes,73 and the
in vitro mucin degradation potential of microbes is phylo-
genetically widespread.74,75 On the other hand, specialist mucin
degraders may stimulate the growth of other mucosal microbes.
For example, Bacteroides spp. are known to release sulphate from
mucin glycans, which makes them more accessible for further
degradation by other microbes76 and may stimulate the growth of
sulphate-reducing bacteria.77
Finally, microbes may enhance their persistence in the colon
mucosal bioﬁlm by specializing to colonise niches at the colon
epithelial surface. An example of such a niche is the intestinal
crypt. Crypts are vulnerable sites of the gut epithelium as they
contain stem cells and are the site of epithelial proliferation and
restitution. In healthy rodents, crypt-associated microbes have
been detected in the caecum and proximal colon, but not in the
distal colon and rectum.36,78,79 Likewise, healthy human rectal
crypts were found to be devoid of bacteria.80,81 Crypt-associated
microbes in the human proximal colon have not been studied so
far owing to the difﬁculties with obtaining correct and unbiased
samples. The crypt micro-environment is proposed to be
characterized by a low mucous viscosity,36 a high partial oxygen
pressure that selects for aerobic species in mice79 and the
presence of speciﬁc types and concentrations of host glycans
mediating saturable crypt occupancy by Bacteroides spp.17
Interestingly, glycan-mediated crypt occupancy by Bacteroides
was found to be responsible for its stable colonisation of the gut,
even in the event of enteric infection or following antibiotic
treatment.17 The authors therefore proposed that crypt-associated
microbiota might represent bacterial reservoirs of founder cells
that repopulate the gut following disruption by infections or
antibiotic consumption.17
Altogether, it has become evident that the colon mucosa
is a unique and highly structured gut environment. The
combination of radial gradients in rigidity, ﬂuid shear and oxygen
concentrations, and the presence of antimicrobial host secretions
and a distinct nutrient pool creates a variety of microbial
microenvironments that result in a speciﬁc bioﬁlm stratiﬁcation
or architecture that impact mucosal bioﬁlm composition and
functionality. On the other hand, microbes seem to actively
participate in shaping the mucosal environment, for example, by
degrading mucus and affecting mucous viscosity or triggering the
production of AMPs.
Although the composition of the mucosal bioﬁlm seems to
correlate with health status, insight into the intrinsic relation
between mucosal microbes and their environment could hold
exciting perspectives for monitoring and modulating human
health. Particular interest thereby goes to the interrelated and
simultaneous impact of the different microenvironmental factors
on mucosal bioﬁlm functioning, in both health and disease.
Overall, such research efforts should help in identifying (i) what
mucosal species and/or microbial functionalities are crucial for
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maintaining a healthy mucosal barrier, (ii) how the immune
system copes with these mucosal microbes and what role
mucolytic activity from speciﬁc gut microbes has in modulating
human health.
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